The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Antibiotic Adjuvants: Make Antibiotics Great Again!
Open accessAbstract
Multiple approaches have been developed to combat bacterial resistance. However, the combination of antibiotic resistance mechanisms by bacteria and the limited number of effective antibiotics available decreases the effective interventions for the treatment of current bacterial infections. This review covers the many ways that bacteria resist antibiotics including antibiotic target modification, the use of efflux pumps, and antibiotic inactivation. As a pertinent example, the use of beta lactamase inhibitors in combination with β-lactam containing antibiotics is discussed in detail. The solution to emerging antibiotic resistance may involve combination therapies of existing antibiotics and potentiating adjuvants, which re-empower the antibiotic agent to become efficacious against the resistant strain of interest. We report herein that a reasoned adjuvant design permits one to perform polypharmacy on bacteria by not only providing greater internal access to the codosed antibiotics but also by de-energizing the efflux pumps used by the bacteria to escape antibiotic action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,052
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Agents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
The antibiotic resistome: the nexus of chemical and genetic diversity
Wright, G. D. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1614 · Cited by 1,365
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Proton-dependent multidrug efflux systems
Paulsen, I. T., Brown, M. H., & Skurray, R. A. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.4.575-608.1996 · Cited by 1,198
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Action and resistance mechanisms of antibiotics: A guide for clinicians
Kapoor, G., Saigal, S., & Elongavan, A. (2017) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_349_15 · Cited by 1,022
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Bennett, P. M. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707607 · Cited by 893
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
The importance of efflux pumps in bacterial antibiotic resistance
Webber, M. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg050 · Cited by 853
Plasmid-Determined AmpC-Type β-Lactamases
Philippon, A., Arlet, G., & Jacoby, G. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.1-11.2002 · Cited by 816
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions
Cox, G., & Wright, G. D. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.009 · Cited by 697
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.1.88-134.1987 · Cited by 686
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., & Terán, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 549
Molecular mechanisms of antibiotic resistance
Wright, G. D. (2011) · Chemical Communications · doi:10.1039/c0cc05111j · Cited by 443
Cathelicidins - a family of multifunctional antimicrobial peptides
Bals, R., & Wilson, J. M. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2186-9 · Cited by 427
English, A. R., Retsema, J. A., Girard, A. E., Lynch, J. E., & Barth, W. E. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.3.414 · Cited by 404
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Durand-Réville, T. F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485979 · Cited by 372
Therapeutic strategies to combat antibiotic resistance
Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 367
Antibiotic Resistance Mechanisms in Bacteria: Biochemical and Genetic Aspects
Kos, B., Džidić, S., & Šušković, J. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 362
Antibiotic Resistance Mechanisms of Clinically Important Bacteria
Giedraitienė, A., Vitkauskienė, A., Naginienė, R., & Pavilonis, A. (2011) · Medicina · doi:10.3390/medicina47030019 · Cited by 362
Mechanisms of antibiotic resistance
Lin, J., Nishino, K., Roberts, M. C., Tolmasky, M., Aminov, R. I., & Zhang, L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00034 · Cited by 343
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Resistance to polymyxins: Mechanisms, frequency and treatment options
Falagas, M. E., Rafailidis, P. I., & Matthaiou, D. K. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.002 · Cited by 298
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria
Bolla, J.-M., Alibert-Franco, S., Handzlik, J., Chevalier, J., Mahamoud, A., Boyer, G., Kieć-Kononowicz, K., & Pagès, J.-M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.054 · Cited by 250
The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?
Melander, R. J., & Melander, C. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00071 · Cited by 250
Antibiotic adjuvants: multicomponent anti-infective strategies
Kalan, L., & Wright, G. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001766 · Cited by 249
The origins and molecular basis of antibiotic resistance
Hawkey, P. M. (1998) · BMJ · doi:10.1136/bmj.317.7159.657 · Cited by 221
Ceragenins: Cholic Acid-Based Mimics of Antimicrobial Peptides
Lai, X.-Z., Feng, Y., Pollard, J., Chin, J. N., Rybak, M. J., Bucki, R., Epand, R. F., Epand, R. M., & Savage, P. B. (2008) · Accounts of Chemical Research · doi:10.1021/ar700270t · Cited by 214
Beta-lactamase inhibitors from laboratory to clinic
Bush, K. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.1.109 · Cited by 212
Van Bambeke, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg224 · Cited by 203
White, A. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh050 · Cited by 198
Fiamegos, Y. C., Kastritis, P. L., Exarchou, V., Han, H., Bonvin, A. M. J. J., Vervoort, J., Lewis, K., Hamblin, M. R., & Tegos, G. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018127 · Cited by 190
Antibiotic combinations: should they be tested?
Eliopoulos, G. M., & Eliopoulos, C. T. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.139 · Cited by 189
The potential management of resistant infections with non-antibiotics
Kristiansen, J. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.319 · Cited by 174
Inhibitors of Multidrug Resistant Efflux Systems in Bacteria
Zechini, B., & Versace, I. (2009) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489109787236256 · Cited by 172
Bambeke, F., Pages, J.-M., & Lee, V. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106777452692 · Cited by 171
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
Blizzard, T. A., Chen, H., Kim, S., Wu, J., Bodner, R., Gude, C., Imbriglio, J., Young, K., Park, Y.-W., Ogawa, A., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.101 · Cited by 168
Martins, M., Dastidar, S. G., Fanning, S., Kristiansen, J. E., Molnar, J., Pagès, J.-M., Schelz, Z., Spengler, G., Viveiros, M., & Amaral, L. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.025 · Cited by 161
Microbial Efflux Pump Inhibition: Tactics and Strategies
Tegos, G. P., Haynes, M. K., Strouse, J. J., Khan, M. M. T., Bologa, C., Oprea, T. I., & Sklar, L. A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795703726 · Cited by 158
The bacterial envelope as a target for novel anti-MRSA antibiotics
Françoise Van Bambeke, A., Mingeot‐Leclercq, M., Struelens, M. J., & Tulkens, P. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.004 · Cited by 149
Bhardwaj, A. K., & Mohanty, P. (2012) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489112799829710 · Cited by 148
Predictable and unpredictable evolution of antibiotic resistance
Courvalin, P. M. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01940.x · Cited by 145
Cyclic Boronates Inhibit All Classes of β-Lactamases
Cahill, S. T., Cain, R. M., Wang, D. Y., Lohans, C. T., Wareham, D. W., Oswin, H. P., Mohammed, J., Spencer, J., Fishwick, C. W. G., McDonough, M. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02260-16 · Cited by 135
Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa
Siriyong, T., Srimanote, P., Chusri, S., Yingyongnarongkul, B., Suaisom, C., Tipmanee, V., & Voravuthikunchai, S. P. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1913-y · Cited by 133
Amaral, L., Martins, M., & Viveiros, M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl500 · Cited by 132
Li, C., Peters, A. S., Meredith, E. L., et al. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973881r · Cited by 125
Dutta, N. K., Annadurai, S., Mazumdar, K., Dastidar, S. G., Kristiansen, J. E., Molnar, J. A., Martins, M., & Amaral, L. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.04.018 · Cited by 125
Polymyxins and their novel derivatives
Vaara, M. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.002 · Cited by 124
Li, C., Budge, L. P., Driscoll, C. D., Willardson, B. M., Allman, G. W., & Savage, P. B. (1999) · Journal of the American Chemical Society · doi:10.1021/ja982938m · Cited by 122
Alonso, A., Campanario, E., & Martínez, J. L. (1999) · Microbiology · doi:10.1099/00221287-145-10-2857 · Cited by 119
Malléa, M., Mahamoud, A., Chevalier, J., Alibert, S., Brouant, P., Barbe, J., & Pagès, J. (2003) · Biochemical Journal · doi:10.1042/bj20030963 · Cited by 117
Extended-Spectrum β-Lactamases (ESBLs): Characterization, Epidemiology and Detection
Shah, A. A., Hasan, F., Ahmed, S., & Hameed, A. (2004) · Critical Reviews in Microbiology · doi:10.1080/10408410490266429 · Cited by 102
Antimicrobial Activities of Ceragenins against Clinical Isolates of Resistant Staphylococcus aureus
Chin, J. N., Rybak, M. J., Cheung, C. M., & Savage, P. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01325-06 · Cited by 101
-Lactamase Inhibition and In Vitro Activity of Sulbactam and Sulbactam/Cefoperazone
Williams, J. D. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.494 · Cited by 95
Antimicrobial activities of squalamine mimics
Kikuchi, K., Bernard, E. M., Sadownik, A., Regen, S. L., & Armstrong, D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1433 · Cited by 94
Cyclic Boronates Inhibit All Classes of β-Lactamase
Cahill, S. T., Cain, R. M., Wang, D. Y., Lohans, C. T., Wareham, D. W., Oswin, H. P., Mohammed, J., SPENCER, J. M., Fishwick, C. W. G., McDonough, M. A., et al. (2017) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 91
Nikaido, H., & Zgurskaya, H. I. (1999) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-199912000-00001 · Cited by 80
Salmi, C., Loncle, C., Vidal, N., Letourneux, Y., Fantini, J., Maresca, M., Taïeb, N., Pagès, J., & Brunel, J. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002765 · Cited by 75
Self-citationWhalen, K. E., Poulson‐Ellestad, K. L., Deering, R. W., Rowley, D. C., & Mincer, T. J. (2015) · Journal of Natural Products · doi:10.1021/np500775e · Cited by 75
Structural Insights into Outer Membrane Permeability of Acinetobacter baumannii
Zahn, M., Bhamidimarri, S. P., Baslé, A., Winterhalter, M., & van den Berg, B. (2016) · Structure · doi:10.1016/j.str.2015.12.009 · Cited by 74
Page, M. G. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0137 · Cited by 73
Antimicrobial Activities of Amine- and Guanidine-Functionalized Cholic Acid Derivatives
Li, C., Lewis, M. R., Gilbert, A. B., Noel, M. D., Scoville, D. H., Allman, G. W., & Savage, P. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1347 · Cited by 73
Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance
Pieren, M., & Tigges, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.005 · Cited by 64
Andrade, J. C., Morais‐Braga, M. F. B., Guedes, G. M. D. M., Tintino, S. R., de Freitas, M. A., Quintans‐Júnior, L. J., de Menezes, I. R. A., & Coutinho, H. D. M. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2015.09.004 · Cited by 64
Dzyubak, E., & Yap, M.-N. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01806-16 · Cited by 64
Pieri, C., Borselli, D., Giorgio, C. D., Méo, M. D., Bolla, J., Vidal, N., Combes, S., & Brunel, J. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500194e · Cited by 58
Self-citationKanagaratnam, R., Sheikh, R., Alharbi, F., & Kwon, D. H. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.10.010 · Cited by 57
Katsu, T., Nakagawa, H., & Yasuda, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1073-1079.2002 · Cited by 52
Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties
Seil, M., Nagant, C., Dehaye, J., Vandenbranden, M., & Lensink, M. F. (2010) · Pharmaceuticals · doi:10.3390/ph3113435 · Cited by 50
Effects of chlorpromazine on the cell envelope proteins of Escherichia coli
Amaral, L., & Lorian, V. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1923 · Cited by 50
Squalamine, an original chemosensitizer to combat antibiotic-resistant Gram-negative bacteria
Lavigne, J., Brunel, J. M., Chevalier, J., & Pagès, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq031 · Cited by 45
Self-citationLi, Y., Sun, X., Feng, J., & Mo, H. (2015) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2015.07.009 · Cited by 42
Mode of action of novel polyamines increasing the permeability of bacterial outer membrane
Yasuda, K., Ohmizo, C., & Katsu, T. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.01.006 · Cited by 42
Claramines: A New Class Of Broad‐Spectrum Antimicrobial Agents With Bimodal Activity
Blanchet, M., Borselli, D., Rodallec, A., Peiretti, F., Vidal, N., Bolla, J., Giorgio, C. D., Morrison, K. R., Wuest, W. M., & Brunel, J. M. (2018) · ChemMedChem · doi:10.1002/cmdc.201800073 · Cited by 41
Self-citationYasuda, K., Ohmizo, C., & Katsu, T. (2003) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(02)00255-5 · Cited by 37
Borselli, D., Lieutaud, A., Théfenne, H., Garnotel, É., Pagès, J., Brunel, J. M., & Bolla, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154490 · Cited by 36
Self-citationYenn, T. W., Khan, M. A., Rozman, N. A. S., Ring, L. C., Ibrahim, D., & Tan, W. (2017) · Steroids · doi:10.1016/j.steroids.2017.10.016 · Cited by 33
Synthetic Membrane-Targeted Antibiotics
Vooturi, S. K., & Firestine, S. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791331059 · Cited by 31
Chusri, S., Na-Phatthalung, P., Siriyong, T., Paosen, S., & Voravuthikunchai, S. P. (2013) · Microbiological Research · doi:10.1016/j.micres.2013.09.004 · Cited by 30
Brunel, J. M., Lieutaud, A., Lôme, V., Pagès, J., & Bolla, J. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.12.030 · Cited by 29
Self-citationBorselli, D., Blanchet, M., Bolla, J., Muth, A., Skruber, K., Phanstiel, O., & Brunel, J. M. (2017) · ChemBioChem · doi:10.1002/cbic.201600532 · Cited by 29
Self-citationCeragenins – a new weapon to fight multidrug resistant bacterial infections
Surel, U., Niemirowicz, K., Marzec, M., Savage, P. B., & Bucki, R. (2014) · Medical Studies · doi:10.5114/ms.2014.45428 · Cited by 26
von Nussbaum, F., & Schiffer, G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407921 · Cited by 23
Reservoirs of resistance: To understand why antibiotics fail, geneticists chase the 'resistome'
Chakradhar, S. (2016) · Nature Medicine · doi:10.1038/nm1016-1069 · Cited by 11
Mechanisms of antibiotic resistance and delivery strategies to prevent its emergence
Khoder, M., Tsapis, N., & Fattal, E. (2010) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(10)50072-8 · Cited by 9
Cited by
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
Song, M., Liu, Y., Huang, X., Ding, S., Wang, Y., Shen, J., & Zhu, K. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0723-z · Cited by 484
α-Pinene: A never-ending story
Allenspach, M., & Steuer, C. (2021) · Phytochemistry · doi:10.1016/j.phytochem.2021.112857 · Cited by 273
Mutalik, V. K., & Arkin, A. P. (2022) · iScience · doi:10.1016/j.isci.2022.104121 · Cited by 32
Liu, J., Ren, A., Miao, Z., Zhou, T., Zhang, C., Chang, Y., Zhao, S., Hu, X., Zhang, X., Jia, T., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00871-y
Metadata
- Authors
- Douafer, H., Andrieu, V., Phanstiel, O., & Brunel, J. M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-05-07
- Volume
- 62
- Issue
- 19
- Pages
- 8665-8681
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2943885243
- Cited by
- 272
- References
- 101
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.